NCT00736034 - The Efficacy of Phosphatidylserine-Omega3 in Elderly Subjects With Memory Impairment | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

March 31, 2009

Study Completion Date

April 30, 2009

Conditions

Memory Impairment

Interventions

DIETARY_SUPPLEMENT

Phosphatidylserine-Omega3 (SharpPS™-Gold)

Treatment will consist of capsules containing 100 mg phosphatidylserine-Omega3. Dosage: 1 capsule X 3 times daily, with meals. Duration: 15 weeks

Trial Locations (1)

The Tel Aviv Sourasky Medical Center, Neurology department, Tel Aviv